GU Cancer Clinical Trials

DISCLAIMER: All content found on cua.org is provided for information and education purposes. The medical information and clinical trials information is not intended to substitute for the advice of a physician, nor is it intended to provide legal advice. You should always consult your doctor for specific information on personal health matters, or other relevant professionals to ensure that your own circumstances are considered.

The CUA is not responsible in any manner for direct, indirect, special or consequential damages caused and/or arising from your use of cua.org.

Subspecialty
Bladder | ON | Not yet recruiting
TRAVELLER
A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer
Pfizer Run

NCT #: NCT05699135

SPONSOR: CHU de Quebec-Universite Laval in Collaboration with Cancer Research Society

INFO: https://classic.clinicaltrials.gov/ct2/show/NCT05699135?cond=UROTHELIAL&cntry=CA&draw=2&rank=7

CONTACT: 1-800-718-1021            

ClinicalTrials.gov_Inquiries@pfizer.com

Other Canadian Centres:

Bayshore Specialty Rx (Mississauga, ON)

Bladder | ON | Recruiting
BL13F
Electronic 'Real-Time' Patient Self-Reporting of Immunotherapy Symptomatic Adverse Events using the SYMPTOM-IQ Tool on the uMotif Mobile Health Application (APP): A Prospective Feasibility Sub-Study of BL13 [e-PRISM]
Dr. Doris Howell (UHN)

CONTACT: (416) 946-4501 Ext. 3419

Bladder | BC | Not yet recruiting
ST-02
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
Dr. Peter Black

NCT #: NCT06124976

SPONSOR: University of British Columbia

INFO: https://classic.clinicaltrials.gov/ct2/show/NCT06124976

CONTACT: Dasa Durkotova

Tel.: 236-869-3437

Email: ddurkotova@prostatecentre.com

Renal | ON, QC | Recruiting
NCI-2014-01984
Study of PF-07265807 in Participants With Metastatic Solid Tumors
Pfizer

NCT #: NCT04458259

SPONSOR: Pfizer

INFO: https://clinicaltrials.gov/ct2/show/NCT04458259?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=32

CONTACT: ClinicalTrials.gov_Inquiries@pfizer.com

OTHER CANADIAN CENTRES:

Juravinski Cancer Centre (Hamilton)                                                    

University Health Network (Toronto)                                                          

CHU de Quebec Universite Laval (Quebec City)

Bladder | BC | Not yet recruiting
LS-URO Study
Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)
Dr. Jussi Nikkola (Finland)

NCT #: NCT06218433

SPONSOR: Tampere University Hospital (Finland)

INFO: https://classic.clinicaltrials.gov/ct2/show/NCT06218433?cond=UROTHELIAL&cntry=CA&draw=2&rank=4

CONTACT: Canadian Contact: Dr. Peter Black

Other Canadian Centres:

1) Vancouver (currently not yet recruiting) and only Canadian site listed.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy